Clinical Trial Update: Retrospective Analysis of Response Markers and Adverse Events in Melanoma Patients Treated With Pembrolizumab

View source ↗

Summary

Retrospective analysis of melanoma patients treated with pembrolizumab evaluating response markers and adverse events to understand associations with efficacy a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• KEYTRUDA (PEMBROLIZUMAB)

Snippet

Sponsor: University Medical Center Groningen | Conditions: Melanoma | Status: COMPLETED